JO1930B1 - مستحضرات نشيطة حيويا - Google Patents

مستحضرات نشيطة حيويا

Info

Publication number
JO1930B1
JO1930B1 JO19961930A JOP19961930A JO1930B1 JO 1930 B1 JO1930 B1 JO 1930B1 JO 19961930 A JO19961930 A JO 19961930A JO P19961930 A JOP19961930 A JO P19961930A JO 1930 B1 JO1930 B1 JO 1930B1
Authority
JO
Jordan
Prior art keywords
acyl
alcohol group
fatty alcohol
bioactives
presentation
Prior art date
Application number
JO19961930A
Other languages
English (en)
Inventor
فريدريك هوروبين ديفيد
مانكو ميهار
ريدين بيتر
Original Assignee
سكوتيا هولدينجز بي ال سي
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by سكوتيا هولدينجز بي ال سي filed Critical سكوتيا هولدينجز بي ال سي
Application granted granted Critical
Publication of JO1930B1 publication Critical patent/JO1930B1/ar

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

المركبات التالية من 1،3 – بروبين ذات التركيبة المرتبطة لعند استخدامها في العلاج حيث تتكون ر1 من مجموعة الاسيل او الكحول الدهني المشتق من ك 12- 30 ويفضل حمض دهني من ك 16- 30 ويفضل ان تتكون من اثنين او اكثر من الروابط المزدوجة سيز او كرانسي الرابطة المزدوجة على جانب واحد او تعبر بينهما . ور2 هو هيدروجين مجموعة 1 اسيل او كحول دهني مثل ر1 او مختلفة عند او أية مادة مغذية او دواء او بقايا مادة حيوية نشطة.
JO19961930A 1995-05-01 1996-05-02 مستحضرات نشيطة حيويا JO1930B1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9508823.3A GB9508823D0 (en) 1995-05-01 1995-05-01 Drug Derivatives

Publications (1)

Publication Number Publication Date
JO1930B1 true JO1930B1 (ar) 1997-01-15

Family

ID=10773801

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19961930A JO1930B1 (ar) 1995-05-01 1996-05-02 مستحضرات نشيطة حيويا

Country Status (5)

Country Link
CN (1) CN100391930C (ar)
GB (1) GB9508823D0 (ar)
JO (1) JO1930B1 (ar)
UA (1) UA61884C2 (ar)
ZA (3) ZA963360B (ar)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
ES2151277T3 (es) * 1996-05-22 2000-12-16 Protarga Inc Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
ES2252874T3 (es) * 1997-12-12 2006-05-16 Purdue Research Foundation Utilizacion de acido linoleico conjugado para tratamiento de la diabetes mellitus tipo ii.
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
BR0107933A (pt) * 2000-01-28 2004-01-06 Procter & Gamble Compostos de arginina saborosos e seus usos para saúde cardiovascular
US8288369B2 (en) * 2006-06-27 2012-10-16 University Of South Florida Delta-tocotrienol treatment and prevention of pancreatic cancer
CN102260177A (zh) * 2010-05-25 2011-11-30 中国医学科学院药物研究所 丙二醇类衍生物、其制备方法和其药物组合物与用途
CN102260178A (zh) * 2010-05-25 2011-11-30 中国医学科学院药物研究所 羟基丙二醇类衍生物、其制备方法和其药物组合物与用途
US9084826B2 (en) * 2012-05-01 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid conjugates of statin and FXR agonists; compositions and method of uses
CN106957307B (zh) * 2017-03-27 2019-06-28 淮阴工学院 一种丹曲林钠衍生物及其制备方法

Also Published As

Publication number Publication date
CN1189148A (zh) 1998-07-29
ZA963397B (en) 1996-08-07
ZA963360B (en) 1996-08-20
GB9508823D0 (en) 1995-06-21
CN100391930C (zh) 2008-06-04
ZA963433B (en) 1996-08-07
UA61884C2 (en) 2003-12-15

Similar Documents

Publication Publication Date Title
MY118354A (en) 1,3-propane diol derivatives as bioactive compounds
JO1930B1 (ar) مستحضرات نشيطة حيويا
CA2088909A1 (en) Enzymic alteration of hair growth
AU7593991A (en) Cosmetic composition
FI970298A0 (fi) DHA:n käyttö farmaseuttisena koostumuksena
CA2195419A1 (en) Immunological activity of rhamnolipids
AU6333794A (en) Retinoid composition
AU2374092A (en) Thin film depolymerization to dimeric cyclic esters
IT1263013B (it) Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
AU5334894A (en) Compositions of fatty acid esters of hexitans
CA2202339A1 (en) Skin care compositions containing melinamide and a retinoid
CA2067365A1 (en) Illudin analogs as anti-tumor agents
BG104470A (en) The use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases
NZ237513A (en) Retinoic acid esters, preparation and pharmaceutical/cosmetic compositions thereof
EP0719541A4 (en) SKIN ACTIVATOR THAT SPEEDS UP GLOCOSAMINGLY CAN PRODUCTION
CA2166468A1 (en) Cleansing Compositions Containing an Alkanoate as Conditioner
ES2167008T3 (es) Procedimiento de produccion de derivados de diol-1,3 naturales y de derivados de 1,3-dioxano naturales correspondientes.
ES2058047T3 (es) Resolucion de acido arilalcanoico.
AU4299696A (en) Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
MX9708386A (es) Derivados de 1,3-propanodiol como compuesto bioactivos.
CA2075926A1 (en) Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them
CA2105683A1 (en) N-¬¬4,5-dihydroxy-and 4,5,8-trihydroxy-9,10-dihydro-9, 10-dioxo-2-anthracene-yl|carbonyl|amino acids useful in the therapy of osteoarticular affections
AU4219496A (en) Inhibiting anaerobic production of volatile fatty acids and hydrogen by bacteria
CA2098102A1 (en) Alteration of rate and character of hair growth
JPS6448899A (en) Detergent composition